BE901095A - NOVEL ANTHELMINTHIC COMPOSITIONS AND THEIR PREPARATION. - Google Patents

NOVEL ANTHELMINTHIC COMPOSITIONS AND THEIR PREPARATION.

Info

Publication number
BE901095A
BE901095A BE0/214033A BE214033A BE901095A BE 901095 A BE901095 A BE 901095A BE 0/214033 A BE0/214033 A BE 0/214033A BE 214033 A BE214033 A BE 214033A BE 901095 A BE901095 A BE 901095A
Authority
BE
Belgium
Prior art keywords
novel
preparation
anthelminthic compositions
anthelminthic
compositions
Prior art date
Application number
BE0/214033A
Other languages
French (fr)
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of BE901095A publication Critical patent/BE901095A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Une composition pharmaceutique qui comprend le sel de nitroxynil de lévamisole en solution dans un solvant comprenant du diméthylisosorbide, du glycofurol ou un mélange des deux et contenant jusqu'à 40 % (poids/volume) de sel de nitroxynil de lévamisole. Cette composition possède des propriétés anthelminthiques et est utilisée dans la lutte contre l'helminthiose. Par ailleurs, elle se présente sous la forme d'un dosage unitaire et est destinée à une administration parentérale.A pharmaceutical composition which comprises the nitroxynil salt of levamisole dissolved in a solvent comprising dimethylisosorbide, glycofurol or a mixture of the two and containing up to 40% (weight / volume) of levroisole nitroxynil salt. This composition has anthelmintic properties and is used in the fight against helminthiosis. Furthermore, it is in the form of a unit dosage and is intended for parenteral administration.

BE0/214033A 1983-11-21 1984-11-20 NOVEL ANTHELMINTHIC COMPOSITIONS AND THEIR PREPARATION. BE901095A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838331037A GB8331037D0 (en) 1983-11-21 1983-11-21 Compositions of matter

Publications (1)

Publication Number Publication Date
BE901095A true BE901095A (en) 1985-05-20

Family

ID=10552109

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/214033A BE901095A (en) 1983-11-21 1984-11-20 NOVEL ANTHELMINTHIC COMPOSITIONS AND THEIR PREPARATION.

Country Status (15)

Country Link
JP (1) JPS60123419A (en)
AU (1) AU3564984A (en)
BE (1) BE901095A (en)
CA (1) CA1236402A (en)
CH (1) CH662273A5 (en)
DE (1) DE3442402A1 (en)
DK (1) DK548884A (en)
ES (1) ES537825A0 (en)
FR (1) FR2555047B1 (en)
GB (2) GB8331037D0 (en)
HU (1) HU196307B (en)
IT (1) IT1177262B (en)
NL (1) NL8403528A (en)
NZ (1) NZ210247A (en)
ZA (1) ZA849008B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0147883A3 (en) * 1983-12-21 1986-12-30 Janssen Pharmaceutica N.V. Aqueous non-aggressive anthelmintic pour-on formulations
AU5733986A (en) * 1985-05-13 1986-11-20 Syntex (U.S.A.) Inc. Anthelmintic compositions comprising a benzimidazole derivative and the fasciolicide rafoxanide
IT1223343B (en) * 1987-11-03 1990-09-19 Also Lab Sas PHARMACEUTICAL FORMULATIONS FOR TRANSDERMAL ADMINISTRATION
BRPI0506279B1 (en) 2005-12-16 2018-01-09 Npa - Núcleo De Pesquisas Aplicadas Ltda SYNERGY COMPOSITION OF ANTIHELMINTICS AND NON-DECATED
CN100500648C (en) * 2006-12-29 2009-06-17 浙江工业大学 Synthesizing process of nitro iodo phenol cyanide
BRPI0904365A2 (en) * 2009-11-05 2011-11-16 Ouro Fino Participacoes E Empreendimentos S A pharmaceutical associations, pharmaceutical compositions, medicament and method of treating animals
MX348079B (en) * 2010-12-27 2017-05-25 Intervet Int Bv Topical localized isoxazoline formulation comprising glycofurol.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4082881A (en) * 1976-12-23 1978-04-04 E. R. Squibb & Sons, Inc. Topical and other type pharmaceutical formulations containing isosorbide carrier
AU527154B2 (en) * 1978-12-15 1983-02-17 Pitman-Moore Australia Limited Composition and process
EP0052962B1 (en) * 1980-11-20 1984-05-09 Beecham Group Plc Pharmaceutical compositions containing two beta-lactam derivatives
NZ202422A (en) * 1981-11-25 1985-02-28 Ici Australia Ltd D, l-and l-2,3,5,6-tetrahydro-6-phenylimidazo(2,1-b)thiazolium 4-cyano-2-iodo-6-nitrophenoxide and veterinary compositions

Also Published As

Publication number Publication date
GB8429264D0 (en) 1984-12-27
ES8600933A1 (en) 1985-10-16
DE3442402A1 (en) 1985-05-30
CA1236402A (en) 1988-05-10
IT8423660A0 (en) 1984-11-20
GB8331037D0 (en) 1983-12-29
DK548884D0 (en) 1984-11-19
DK548884A (en) 1985-05-22
NL8403528A (en) 1985-06-17
FR2555047B1 (en) 1987-04-17
HUT35955A (en) 1985-08-28
HU196307B (en) 1988-11-28
IT8423660A1 (en) 1986-05-20
IT1177262B (en) 1987-08-26
GB2150024B (en) 1987-02-04
JPS60123419A (en) 1985-07-02
ZA849008B (en) 1985-07-31
NZ210247A (en) 1988-01-08
FR2555047A1 (en) 1985-05-24
GB2150024A (en) 1985-06-26
AU3564984A (en) 1985-05-30
ES537825A0 (en) 1985-10-16
CH662273A5 (en) 1987-09-30

Similar Documents

Publication Publication Date Title
Veber et al. A super active cyclic hexapeptide analog of somatostatin
IL71326A (en) Corticotropin releasing factor analogs and pharmaceutical compositions containing them
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
EP0327756B1 (en) Pharmaceutical compositions comprising a calcitonin and a glycyrrhizinate as absorption enhancer
TNSN03085A1 (en) RECONSTITUABLE PARENTERAL COMPOSITION CONTAINING A COX-2 INHIBITOR
IL93119A0 (en) Purified intracellular adhesion molecule-1,dna encoding it,its preparation and pharmaceutical compositions containing it
BE901095A (en) NOVEL ANTHELMINTHIC COMPOSITIONS AND THEIR PREPARATION.
BE904233A (en) PEPTIDES AND PEPTIDE DERIVATIVES, THEIR PREPARATION, THEIR USE IN THERAPEUTICS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
BE904796A (en) NOVEL MORPHINANE AND MORPHINE DERIVATIVES, THEIR PREPARATION, THEIR APPLICATION AS MEDICAMENTS AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
US5491171A (en) Pharmaceutical preparation containing prostaglandin compound for rectal or vaginal administration
EP0173664A3 (en) Biologically active benzimidazole compounds and process for their preparation
CA2318326A1 (en) Novel pentasaccharides, processes for their preparation and pharmaceutical compositions containing them
KR920008060A (en) Galactomannan derivatives for coating or sealing pharmaceutical actives
FR2368959A1 (en) COMPOSITIONS CONTAINING GUANIDINOALCANOIC ACID DERIVATIVES, USED AS A MEDICINAL PRODUCT
Scott et al. Further study of some 1-substituted theobromine compounds
US3657436A (en) Method of treating col-sk virus infections
PT84943B (en) METHOD FOR PREPARING PHARMACEUTICAL COMPOSITIONS CONTAINING A MIXTURE OF AT LEAST, A POLYPEPTIDE, A MONOSCAKE AND A POLYOXYL-ETHYLENE-ETER
EP0500586A1 (en) Pyrimidine biosynthesis inhibitors useful as immunosuppressive agents
JP3535207B2 (en) Anticancer agent and GRP receptor antagonist
US3466377A (en) Aralkyl aliphatic sulfoxide oral,parenteral and rectal dosage units for pain,fever and inflammation
IE44117B1 (en) Pharmaceutical compositions having diuretic and antihypertensive activity
CA2167841A1 (en) Method of inhibiting the production of human immunodeficiency viruses with substituted azaspiranes
US3502774A (en) Anthelmintic method using 6-methoxy-1-phenazinol 5,10-dioxide
US3704244A (en) N-lower alkyl-substituted n'-(beta-(2',5'-diphenylpyrolyl - 1')) ethylhomopiperazines
EP0078431A1 (en) Methyl 3-acetamido-2-(5-methoxy-indol-3-yl) propanoate

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: MAY & BAKER LTD

Effective date: 19891130